Literature DB >> 15889967

Adiposopathy, metabolic syndrome, quantum physics, general relativity, chaos and the Theory of Everything.

Harold Bays1.   

Abstract

Excessive fat (adiposity) and dysfunctional fat (adiposopathy) constitute the most common worldwide epidemics of our time -- and perhaps of all time. Ongoing efforts to explain how the micro (adipocyte) and macro (body organ) biologic systems interact through function and dysfunction in promoting Type 2 diabetes mellitus, hypertension and dyslipidemia are not unlike the mechanistic and philosophical thinking processes involved in reconciling the micro (quantum physics) and macro (general relativity) theories in physics. Currently, the term metabolic syndrome refers to a constellation of consequences often associated with excess body fat and is an attempt to unify the associations known to exist between the four fundamental metabolic diseases of obesity, hyperglycemia (including Type 2 diabetes mellitus), hypertension and dyslipidemia. However, the association of adiposity with these metabolic disorders is not absolute and the metabolic syndrome does not describe underlying causality, nor does the metabolic syndrome necessarily reflect any reasonably related pathophysiologic process. Just as with quantum physics, general relativity and the four fundamental forces of the universe, the lack of an adequate unifying theory of micro causality and macro consequence is unsatisfying, and in medicine, impairs the development of agents that may globally improve both obesity and obesity-related metabolic disease. Emerging scientific and clinical evidence strongly supports the novel concept that it is not adiposity alone, but rather it is adiposopathy that is the underlying cause of most cases of Type 2 diabetes mellitus, hypertension and dyslipidemia. Adiposopathy is a plausible Theory of Everything for mankind's greatest metabolic epidemics.

Entities:  

Mesh:

Year:  2005        PMID: 15889967     DOI: 10.1586/14779072.3.3.393

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  13 in total

1.  The prevalence and clinical impact of obesity in adults with Marfan syndrome.

Authors:  Anji T Yetman; Brian W McCrindle
Journal:  Can J Cardiol       Date:  2010-04       Impact factor: 5.223

2.  Adiposopathy: treating pathogenic adipose tissue to reduce cardiovascular disease risk.

Authors:  Harold Bays; Helena W Rodbard; Alan Bruce Schorr; J Michael González-Campoy
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08

3.  Inflammatory "adiposopathy" in major amputation patients.

Authors:  Christine R Mauro; Binh T Nguyen; Peng Yu; Ming Tao; Ian Gao; Michael A Seidman; Louis L Nguyen; C Keith Ozaki
Journal:  Ann Vasc Surg       Date:  2013-04       Impact factor: 1.466

Review 4.  Adiposopathy is a more rational treatment target for metabolic disease than obesity alone.

Authors:  Harold Bays; Carlos A Dujovne
Journal:  Curr Atheroscler Rep       Date:  2006-03       Impact factor: 5.113

5.  An approach to estimate bidirectional mediation effects with application to body mass index and fasting glucose.

Authors:  Rajesh Talluri; Sanjay Shete
Journal:  Ann Hum Genet       Date:  2018-07-11       Impact factor: 1.670

Review 6.  Adiposopathy, "sick fat," Ockham's razor, and resolution of the obesity paradox.

Authors:  Harold Bays
Journal:  Curr Atheroscler Rep       Date:  2014-05       Impact factor: 5.113

Review 7.  Is adiposopathy (sick fat) an endocrine disease?

Authors:  H E Bays; J M González-Campoy; R R Henry; D A Bergman; A E Kitabchi; A B Schorr; H W Rodbard
Journal:  Int J Clin Pract       Date:  2008-08-04       Impact factor: 2.503

8.  The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys.

Authors:  H E Bays; R H Chapman; S Grandy
Journal:  Int J Clin Pract       Date:  2007-05       Impact factor: 2.503

Review 9.  Orlistat in the prevention of diabetes in the obese patient.

Authors:  Marcio C Mancini; Alfredo Halpern
Journal:  Vasc Health Risk Manag       Date:  2008

Review 10.  Bariatric endocrinology: principles of medical practice.

Authors:  J Michael Gonzalez-Campoy; Bruce Richardson; Conor Richardson; David Gonzalez-Cameron; Ayesha Ebrahim; Pamela Strobel; Tiphani Martinez; Beth Blaha; Maria Ransom; Jessica Quinonez-Weislow; Andrea Pierson; Miguel Gonzalez Ahumada
Journal:  Int J Endocrinol       Date:  2014-05-12       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.